Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes (Q60390326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Angel Alberich-Bayarri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Luis Martí-Bonmatí

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Luisa M Villar

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Maria José Magraner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Isabel Bosca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Gracian García-Martí

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Francisco Coret

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bonaventura Casanova

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jose C Alvarez-Cermeño

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

16 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

5-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00234-011-0841-7

22 January 2020

exact match

0 references

cites work

Normalized accurate measurement of longitudinal brain change.

1 reference

12 December 2020

Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis

1 reference

12 December 2020

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

1 reference

12 December 2020

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

1 reference

12 December 2020

Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.

1 reference

12 December 2020

A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease

1 reference

12 December 2020

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

1 reference

12 December 2020

Influence of oligoclonal IgM specificity in multiple sclerosis disease course

1 reference

12 December 2020

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

1 reference

12 December 2020

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

1 reference

12 December 2020

A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images.

1 reference

12 December 2020

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

1 reference

12 December 2020

Is optic neuritis more benign than other first attacks in multiple sclerosis?

1 reference

12 December 2020

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

An ultrasensitive method for the detection of oligoclonal IgG bands

1 reference

12 December 2020

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

12 December 2020

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.

1 reference

12 December 2020

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

1 reference

12 December 2020

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

12 December 2020

Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis

1 reference

12 December 2020

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis

1 reference

12 December 2020

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination

1 reference

12 December 2020

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

12 December 2020

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

1 reference

12 December 2020

Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods

1 reference

12 December 2020

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

12 December 2020

Natural history of multiple sclerosis: a unifying concept

1 reference

12 December 2020

The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis.

1 reference

12 December 2020

10.1007/S00234-011-0841-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21327771%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference